Nitric oxide synthases and cardiovascular signaling

Area of Science:

• Cardiovascular Physiology
• Cellular Signaling
• Neuroendocrinology

Background:

• Nitric oxide (NO), synthesized from L-arginine, is a key intercellular messenger in mammalian cells, including vascular endothelium and neurons.
• NO signaling is crucial for vascular tone and platelet aggregation via guanylate cyclase activation.
• The specific role of NO in directly modulating cardiac function remains less understood.

Purpose of the Study:

• To investigate the role of the nitric oxide (NO) signaling pathway in modulating cardiac function.
• To determine if NO synthase inhibitors affect the response of cardiac myocytes to agonists.

Main Methods:

• Utilized neonatal and adult rat ventricular myocytes.
• Administered muscarinic (carbachol) and adrenergic agonists.
• Applied L-N-monomethylarginine (NO synthase inhibitor) and methylene blue (NO inhibitor).
• Assessed effects on spontaneous beating rate and measured NO production using a reporter cell bioassay.

Main Results:

• Inhibitors of NO synthase and NO blocked the carbachol-induced inhibition of neonatal rat cardiac myocyte beating rate.
• These inhibitors did not affect the basal beating rate of the myocytes.
• Carbachol-stimulated NO production was detected in neonatal myocytes.
• Cyclic guanosine monophosphate (cGMP) analogs mimicked the negative chronotropic effect of carbachol.

Conclusions:

• The nitric oxide (NO) signaling pathway, likely involving cyclic guanosine monophosphate (cGMP), modulates cardiac myocyte function.
• NO mediates the negative chronotropic effects of muscarinic stimulation in neonatal rat cardiac myocytes.
• These findings highlight a novel role for NO in the direct regulation of cardiac activity.